Meédicaments: une cause sous-estimée d'hypertension artérielle [Drugs: an underestimated cause of arterial hypertension].

Details

Serval ID
serval:BIB_D05EC0C0C042
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Meédicaments: une cause sous-estimée d'hypertension artérielle [Drugs: an underestimated cause of arterial hypertension].
Journal
Revue Médicale Suisse
Author(s)
Serveaux M., Burnier M., Pruijm M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
09/2014
Volume
10
Number
441
Pages
1661-2, 1664-5
Language
french
Notes
Publication types: English Abstract ; Journal Article Publication Status: ppublish
Abstract
In Switzerland, as in other Occidental countries, the prevalence of arterial hypertension (AHT) in the adult population is around 30-40%. Among the causes of secondary AHT, drug induced hypertension is sometimes omitted. Many molecules can induce AHT or worsen it due to an interaction with anti hypertensive drugs. Among these, NSAIDs and anti depressants, widely prescribed, should be used with caution, particularly in patients at risk, namely: those with preexisting AHT, the elderly, or patients suffering from kidney disease, diabetes, and/or heart failure. Increases in blood pressure have also been described with anti-vascular endothelial growth factor (VEGF) drugs, used in the treatment of (metastatic) cancer. A thorough anamnesis of drugs, including over the counter ones, should be performed in every hypertensive patient, and can avoid cumbersome and unnecessary investigations and therapy.
Keywords
Adult, Angiogenesis Inhibitors/adverse effects, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Antidepressive Agents/adverse effects, Drug-Related Side Effects and Adverse Reactions, Humans, Hypertension/chemically induced, Hypertension/epidemiology, Nasal Decongestants/adverse effects, hic" UI="D013557">Switzerland/epidemiology, Vascular Endothelial Growth Factor A/antagonists & inhibitors
Pubmed
Create date
15/01/2015 12:02
Last modification date
20/08/2019 15:50
Usage data